期刊文献+

大疱性表皮松解型药疹31例临床分析 被引量:8

A Clinical Analysis of 31 Patients With Drug-induced Bullosa Epidermolysis
下载PDF
导出
摘要 目的探讨大疱性表皮坏死松解型药疹的发病原因、临床表现及治疗经验。方法回顾31例住院治疗的该型药疹患者的发病原因、诊断及治疗经过。结果致病药物包括解热镇痛药、抗生素、抗痛风药、中药等。皮损面积超过体表面积50%为18例(58.1%),黏膜受损者27例(87.1%)。经综合治疗,均痊愈。结论大疱性表皮松解型药疹病因、临床表现复杂;糖皮质类固醇、大剂量免疫球蛋白、适当局部护理及对症支持治疗对治疗大疱性表皮坏死松解型药疹有重要作用。 Objective To explore the causes, clinical features and appropriate therapies of drug-induced bullosa epidermolysis. Methods A retrospective study was performed on 31 patients with drug- induced bullosa epidermolysis. Results The main causative drugs included antipyretics,antibiotics, anti - gout drug and medici- nal herb, and so on. More than 50% of the body surface was involved in 18 cases (58.1% ). Erosive mucous mem- brane lesions were presented in 27 cases ( 87.1% ). By combined therapies, all healed. Conclusions The causes and clinical features of drug - induced bullosa epidermolysis are extremely complicated. The comprehensive therapeutics including corticosteroid , high dose of gamma globulin , supportive treatment, timely management of complications and adequate nursing care of skin and membrane are of utmost importance for curing drug - induced bullosa epidermolysis.
出处 《南华大学学报(医学版)》 2008年第2期203-205,共3页 Journal of Nanhua University(Medical Edition)
关键词 药疹 大疱性表皮坏死松解型 回顾性研究 drug eruption bullosa epidennolysis retrospective study
  • 相关文献

参考文献4

二级参考文献24

  • 1Fritsch PO, Sidoroff A. Drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis. Am J Clin Dermatol, 2000, 1 ( 6 ) : 349 -360. 被引量:1
  • 2Paul C, Wolkenstein P, Adle H, et al. Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis. Br J Dermatol,1996, 134(4) :710 -714. 被引量:1
  • 3Friedmann PS, Stricldand I, Pirmohamed M, et al. Investigation of mechanisms in toxic epidermal neerolysis induced by carbamazepine.Arch Dermatol, 1994, 130(5) :598 -604. 被引量:1
  • 4Stone N, Sheerin S, Burge S. Toxic epidermal necrolysis and graft vs.host disease: a clinical spectrum but a diagnostic dilemma. Clin Exp Dermatol, 1999, 24(4) :260 -262. 被引量:1
  • 5Magina S, Lisboa C, Goncalves E, et al. A case of toxic epidermal necrolysis treated with intravenous immunoglobin. Br J Dermatol,2000, 142( 1 ) :191 - 192. 被引量:1
  • 6Paquet P, Jacob E, Damas P, et al. Treatment of drug-induced toxic epidermal necrolysis (Lyell's syndrome) with intravenous human immunoglobulins. Burns, 2001, 27(6) :652 -655. 被引量:1
  • 7Correia O, Delgado L, Roujeau JC, et al. Soluble interhukin 2 receptor and interleukin 1 alpha in toxic epidermal necrolysis: a comparative analyais of serum and blister fluid samples. Arch Dermatol,2002, 138(1) :29 -32. 被引量:1
  • 8Correia O, De.lgado L, Barbosa IL, et al. CD8 + lymphocytes in the blister fluid of severe acute cutaneous graft-versus-host disease: further similarities with toxic epidermal necrolysis. Dermatology, 2001,203(3) :212 -216. 被引量:1
  • 9Krammer PH. CD95's deadly mission in the immune system. Nature,2000, 407(6805) :789 -795. 被引量:1
  • 10Wolkenstein P, Latarjet J, Roujeau JC, et al. Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis. Lancet,1998, 352 (9140) :1586 - 1589. 被引量:1

共引文献33

同被引文献30

引证文献8

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部